CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes

Benzer Materyaller

• Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
  Yazar:: Lasho, Terra L., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
  Yazar:: Patnaik, Mrinal M., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation
  Yazar:: Patnaik, Mrinal M., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms
  Yazar:: Patnaik, Mrinal M., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Non Hepatosplenic Extramedullary Manifestations of Chronic Myelomonocytic Leukemia: Clinical, Molecular and Prognostic Correlates
  Yazar:: Hoversten, Kate, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)